Thalassemia. Beta thalassemia
Conditions
Interventions
Intervention 1: In the first intervention group, Avisirox is prescribed to each patient daily at a dose of 40-20 mg/kg for 6 months. Intervention 2: In the second intervention group, each patient is p
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to No maximum
Inclusion criteria
Inclusion criteria: Thalassemia patients with ferritin greater than 500 Patients who need frequent blood transfusions Indication of receiving chelator At least 2 years old
Exclusion criteria
Exclusion criteria: History of liver and kidney failure History of high blood pressure, skin, respiratory and hearing diseases History of taking iron supplements
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Respiratory complications. Timepoint: The beginning of the study, three and six months after the end of the study. Method of measurement: Asking the patient and doctor visits.;Skin complications. Timepoint: The beginning of the study, three and six months after the end of the study. Method of measurement: Asking the patient and doctor visits.;Digestive complications. Timepoint: The beginning of the study, three and six months after the end of the study. Method of measurement: Asking the patient and doctor visits. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mohammad Reza Golpaigani
Kermanshah University of Medical Sciences
Outcome results
None listed